Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
CTRL Therapeutics Launches with $10M Seed Financing to Advance Next-Generation Cell Therapy Platform for the Treatment of Solid Tumors
CTRL Therapeutics, a biotechnology company developing a next-generation cell therapy platform for solid tumors, has […]
Ultima Genomics and Genome Insight Collaborate to Bring Affordable Whole Genome Sequencing to Cancer Patients
Ultima Genomics and Genome Insight have signed an agreement to collaborate to bring affordable whole […]
Consumer Longevity Company Tally Health™ Announces $10M Seed Round Led by Forerunner Ventures with Celebrity Participation
Tally Health, a revolutionary consumer biotechnology company created to change the way we age, announces […]
Life-Saving NHS Test Helping To Diagnose Thousands With Cancer-Causing Syndrome
A life-saving NHS testing programme is helping to diagnose thousands of people with a genetic […]
Canaan Closes $850 Million to Continue 35-Year History of Building and Supporting Transformational Technology and Healthcare Companies
Canaan today announced $850 million in new capital to continue the firm’s 35-year history of […]
CRISPR QC Co-founder Kiana Aran Makes Inc.’s 2023 Female Founders List
CRISPR QC is proud to announce that co-founder Kiana Aran has been recognized by Inc. […]
Lipella Pharmaceuticals Doses First Patient in Human Study of Innovative Contrast Agent
Lipella Pharmaceuticals, a clinical-stage biotechnology company addressing serious diseases with significant unmet needs, today announces […]
Synthego Launches Express Cell Pools for Faster, More Efficient Genome Editing
Synthego, a leading provider of genome engineering solutions, has announced the launch of Express Knockout […]
Nona Biosciences Enters into Collaboration Agreement with ExeVir Bio
Nona Biosciences, a wholly-owned subsidiary of HBM Holdings Limited, committed to cutting-edge technology innovation and […]
Ochre Bio Strengthens Leadership Team and Board of Directors with Liver Disease Translational Expertise
Ochre Bio, an innovator in chronic liver disease medicine development, is pleased to announce the […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more